Contemporary Treatment of Metastatic Renal Cell Carcinoma

The introduction of targeted therapy has revolutionized the treatment of patients with metastatic renal cell carcinoma (mRCC). The current standard of care focuses on the inhibition of angiogenesis through the targeting of the vascular endothelial growth factor receptor (VEGFR) and the mammalian tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Stukalin, Igor, Alimohamed, Nimira, Heng, Daniel Y.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943094/
https://www.ncbi.nlm.nih.gov/pubmed/27471582
http://dx.doi.org/10.4081/oncol.2016.295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943094/
https://www.ncbi.nlm.nih.gov/pubmed/27471582
http://dx.doi.org/10.4081/oncol.2016.295

Ejemplares similares